• Corpus ID: 9678526

ect of Lactobacillus reuteri Supplementation in Adults with Chronic Functional Constipation : a Randomized , Double-Blind , Placebo-Controlled Trial *

  title={ect of Lactobacillus reuteri Supplementation in Adults with Chronic Functional Constipation : a Randomized , Double-Blind , Placebo-Controlled Trial *},
  author={Veronica Ojetti and Gianluca Ianiro and Annalisa Tortora and Giovanna D ‘ Angelo and Teresa Antonella Di Rienzo and Stefano Bibb{\`o} and Alessio Migneco and Antonio Gasbarrini},
Background & Aims: ere is a growing interest for the use of probiotics for chronic constipation. A recent randomized controlled trial (RCT) showed a positive e ect of Lactobacillus reuteri (L. reuteri) on bowel movement frequency in infants with chronic constipation. e aim of the present study was to evaluate the e ects of L. reuteri in adult patients with functional constipation. Methods: A double-blind, placebo RCT was conducted in 40 adults (18M/22F, 35±15 years) a ected by functional… 

Figures and Tables from this paper

The gut‐brain axis in Parkinson's disease: Possibilities for food‐based therapies



Systematic review of randomised controlled trials: probiotics for functional constipation.

Until more data are available, it is believed the use of probiotics for the treatment of constipation condition should be considered investigational.

The role of a probiotics mixture in the treatment of childhood constipation: a pilot study

This pilot study shows that a mixture of probiotics, has positive effects on symptoms of constipation, and a large randomised placebo controlled trial is required to confirm these findings.

Probiotic beverage containing Lactobacillus casei Shirota improves gastrointestinal symptoms in patients with chronic constipation.

The results indicate a beneficial effect on gastrointestinal symptoms of patients with Chronic constipation and the administration of probiotic foodstuffs may be recommended as an adjunctive therapy of chronic constipation.

Treatment of chronic constipation: current pharmacologic approaches and future directions.

  • J. TackS. Müller-lissner
  • Medicine
    Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association
  • 2009

Epidemiology of Constipation in North America: A Systematic Review

Constipation is very common, as approximately 63 million people in North America meet the Rome II criteria for constipation, and minimal data are available regarding incidence, natural history, and quality of life in patients with constipation.

Behavioural and new pharmacological treatments for constipation: getting the balance right

The evidence that behavioural treatment works for evacuation disorders, the new treatment options for constipation not associated with evacuation disorder, and how ‘targeting therapy’ to the underlying diagnosis results in a balanced approach to patients with these common disorders are reviewed.

Recent Advances in the Management of Difficult Constipation

This report will focus on recent advances in the management of difficult constipation, and include a discussion of new and upcoming medications as well as new diagnostic tests and procedures.

Pharmacologic management of chronic constipation.